About Us
Established through the unification of the ACS National HPV Vaccination Roundtable (est. 2014) and the National Roundtable on Cervical Cancer (est. 2022), the ACS National HPV Cancers Roundtable (ACS HPVCRT) brings together diverse voices around the shared goal of eliminating HPV cancers by ensuring access to vaccination, screening, early detection, and treatment. Recognizing the significant burden of cervical and other HPV cancers, leaders across healthcare, public health, advocacy, and research leverage the roundtable as a forum to advance equitable solutions, drive collective action, and improve health outcomes for all communities.
Guided by our vision, the ACS HPVCRT serves as a catalyst for innovation and action. Through education, advocacy, and the implementation of evidence-based strategies, we work to close gaps in prevention and care, reduce disparities, and build a future where HPV cancers are prevented, detected early, and ultimately eliminated.
Our Mission
Support partners working toward the elimination of cervical cancer and other HPV cancers by ensuring access to vaccination, screening, early detection, and treatment.
Our Members
The ACS HPVCRT is a coalition of public, private, and voluntary organizations with expertise in HPV vaccination, screening, early detection and treatment through survivorship.
Our People
Meet the chairs, steering committee, and staff guiding the ACS HPVCRT’s work to support efforts to eliminate cervical and other HPV cancers by ensuring access to vaccination, screening, early detection, and treatment.
Standing Committees
The ACS HPVCRT’s work is made possible through the support of member-staffed standing committees: the Membership Committee, the Nominating Committee, and a cross-roundtable Bylaws Committee.
Priority Teams
Through engagement in Priority Teams, ACS HPVCRT members will work together to identify priorities, share expertise, and develop resources and activities that improve access to vaccination, screening, early detection, and treatment while accelerating progress toward the elimination of HPV cancers.
Sign up for emails
Stay informed by joining our email list. Get the latest updates about upcoming forums, webinars, resources, and news delivered to your inbox.